Bionik Laboratories Corp.
BNKLDelisted- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001508381
Bionik Laboratories Corp. was delisted in 2023; its insiders filed their last Form 4 on Jun 21, 2023; no institution reported holding it in 13F filings for Q4 2022; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q4 2022
- 13F value
- $0
- Reported value at the end of Q4 2022
- Superinvestors holding
- 0
- At the end of Q4 2022
Superinvestors holding BNKL, Q4 2022
No superinvestor reported holding BNKL at the end of Q4 2022.
Latest insider trades
Open-market purchases and sales by Bionik Laboratories Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 (view filing) | Jun 13 | 8 daysLate | Auberton-Herve Andre-JacquesDirector | PPurchaseCommon Stock, par value $0.001 per share | +366.7K | $0.60 | +$220.0K | –1 after | DerivativePrice outlier |
| Jun 21, 2023 (view filing) | Jun 9 | 12 daysLate | Matine CharlesDirector | PPurchaseCommon Stock, par value $0.001 per share | +180.6K | $0.60 | +$108.3K | +683.1%207.0K after | |
| Jun 21, 2023 (view filing) | Jun 9 | 12 daysLate | Gaston-Dreyfus RemiDirector, 10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +180.6K | $0.60 | +$108.3K | +11.0%1.81M after | |
| Jun 21, 2023 (view filing) | Jun 9 | 12 daysLate | Auberton-Herve Andre-JacquesDirector | PPurchase | +650.0K | $0.60 | +$390.0K | +238.0%923.2K after | |
| Dec 13, 2021 (view filing) | Mar 26 | 262 daysLate | Gaston-Dreyfus RemiDirector, 10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +135.6K | – | – | +10.6%1.42M after |
Top 10 13F holders, Q4 2022
The largest institutional positions in Bionik Laboratories Corp. at the end of Q4 2022; share changes are against Q3 2022.
No institution reported holding BNKL in 13F filings for Q4 2022.